Why is Torrent Pharma falling/rising?

As of 11-Sep, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,575.30, reflecting a decrease of 14.75 points or 0.41%. The stock has underperformed its sector by 0.88% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 1.62% during this period. Despite this short-term downturn, the company has shown strong performance over the longer term, with a year-to-date return of 6.55% and a remarkable 135.15% increase over the past three years. However, the recent drop in delivery volume by 14.26% against the five-day average suggests a decrease in investor participation, which may be contributing to the stock's current decline.
In the broader market context, the Sensex has gained 1.03% over the past week and 1.17% over the past month, indicating that the overall market is performing positively while Torrent Pharmaceuticals is lagging behind. This underperformance is particularly notable given the company's strong fundamentals, including a high return on capital employed (ROCE) of 22.33% and a low debt-to-EBITDA ratio of 1.26 times, which suggest solid financial health. Despite the recent price drop, the company has consistently delivered positive results over the last eight quarters and has maintained high institutional holdings at 24.75%, indicating confidence from larger investors. However, the stock's inability to capitalize on the broader market gains may be causing concern among investors, leading to its current price decline.